AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Revitalizing UK Clinical Trials
This chapter explores the decline of new clinical trial initiations in the UK from 2017 to 2021, exacerbated by Brexit and COVID-19. It highlights the government's commitment to rejuvenating the life sciences sector through significant investment, regulatory reforms, and streamlined processes. The discussion emphasizes the necessity of effectively leveraging the UK's structural advantages to regain its status as a prime location for clinical research.